Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib adjuvant therapy in renal cell carcinoma after nephrectomy
CTR20131447Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pazopanib in renal cell carcinoma (RCC), sponsored by GSK. Started Dec 2014; status: completed.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on CTR20131447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131447.